Endometrial Intraepithelial Neoplasia (EIN) in Endometrial Biopsy Specimens Categorized by the 1994 World Health Organization Classification for Endometrial Hyperplasia

  • Li, Xiao-Chao (Department of Pathology, Basic Medical College, Tianjin Medical University) ;
  • Song, Wen-Jing (Department of Pathology, Basic Medical College, Tianjin Medical University)
  • Published : 2013.10.30


Our study is to determine the presence of endometrial intraepithelial neoplasia (EIN) in endometrial biopsy specimens classified by the 1994 World Health Organization (WHO) criteria for endometrial hyperplasia. Endometrial biopsy specimens that were stained with hematoxylin and eosin (HE) were examined and categorized by the WHO 1994 criteria and for the presence of EIN as defined by the International Endometrial Collaborative Group. ${\beta}$-catenin expression was examined by immunohistochemistry. A total of 474 cases of HE stained endometrial biopsy tissues were reviewed. There were 379 cases of simple endometrial hyperplasia, 16 with simple atypical endometrial hyperplasia, 48 with complex endometrial hyperplasia, and 31 with complex atypical endometrial hyperplasia. Among the 474 endometrial hyperplasia cases, there were 46 (9.7%) that were classified as EIN. Of these 46 cases, 11(2.9%) were classified as simple endometrial hyperplasia, 1 (6.3%) as simple atypical endometrial hyperplasia, 6 (12.5%) as complex endometrial hyperplasia, and 28 (90.3%) as complex atypical endometrial hyperplasia. EIN was associated with a higher rate of ${\beta}$-catenin positivity than endometrium classified as benign hyperplasia (72% vs. 22.5%, respectively, P<0.001), but a lower rate than endometrial adenocarcinoma (72% vs. 96.2%, respectively, P<0.001). In benign endometrial hyperplasia, high ${\beta}$-catenin expression was noted in the cell membranes, whereas in EIN and endometrial adenocarcinoma high expression was noted in the cytoplasm. In conclusion, EIN is more accurate than the WHO classification for the diagnosis of precancerous lesions of the endometrium.


Endometrial hyperplasia;endometrial intraepithelial neoplasia;beta-catenin;World Health Organization


  1. Bergeron C, Nogales FF, Masseroli M, et al (1999). A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am J Surg Pathol, 23, 1102-8.
  2. Baak JP, Mutter GL (2005). EIN and WHO94. J Clin Pathol, 58, 1-6.
  3. Doll A, Abal M, Rigau M, et al (2008). Novel molecular profiles of endometrial cancer-new light through old windows. J Steroid Biochem Mol Biol, 108, 221-9.
  4. Duan GJ, Yan XC, Bian XW, et al (2004). The significance of ${\beta}$-catenin and matrix metalloproteinase-7 expression in colorectal adenoma and carcinoma. Chin J Pathol, 33, 518-22. (in Chinese)
  5. Francz M (2008). The premalignant disease of the endometrium: endometrial intraepithelial neoplasia. Magy Onkol, 52, 35-40. (in Hungarian)
  6. Gultekin M, Diribas K, Dursun P, Ayhan A (2009). Current management of endometrial hyperplasia and endometrial intraepithelial neoplasia (EIN). Eur J Gynaecol Oncol, 30, 396-401.
  7. Horn LC, Meinel A, Handzel R, Einenkel J (2007). Histopathology of endometrial hyperplasia and endometrial carcinoma: an update. Ann Diagn Pathol, 11, 297-311.
  8. Jeong JW, Lee HS, Franco HL, et al (2009). beta-catenin mediates glandular formation and dysregulation of beta-catenin induces hyperplasia formation in the murine uterus. Oncogene, 28, 31-40.
  9. Moreno-Bueno G, Hardisson D, Sarrio D, et al (2003). Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia. J Pathol, 199, 471-8.
  10. Kendall BS, Ronnett BM, Isacson C, et al (1998). Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol, 22, 1012-9.
  11. Kurman RJ, Kaminski PF, Norris HJ (1985). The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer, 56, 403-12.<403::AID-CNCR2820560233>3.0.CO;2-X
  12. Li YJ, Ji XR (2003). Relationship between the expression of ${\beta}$-cat, cyclin D1 and c-myc and the occurrence and biological behavior of pancreatic cancer. Chin J Pathol, 32, 223-41. (in Chinese)
  13. Mutter GL, Baak JP, Crum CP, et al (2000a). Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry. J Pathol, 190, 462-9.<462::AID-PATH590>3.0.CO;2-D
  14. Mutter GL, Lin MC, Fitzgerald JT, et al (2000b). Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst, 92, 924-30.
  15. Mutter GL, Zaino RJ, Baak JP, et al (2007). Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. Int J Gynecol Pathol, 26, 103-14.
  16. Norimatsu Y, Moriya T, Kobayashi TK, et al (2007). Immunohistochemical expression of PTEN and beta-catenin for endometrial intraepithelial neoplasia in Japanese women. Ann Diagn Pathol, 11, 103-8.
  17. Park BH, Vogelstein B, Kinzler KW (2001). Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells. Proc Natl Acad Sci U S A, 98, 2598-603.
  18. Tavassoeli FA, Devilee P (2003). Pathology and Genetics Tumours of the Breast and Female Genital Organs. IARC Press, Lyon. pp 221-232.
  19. Pavlakis K, Messini I, Vrekoussis T, et al (2010). PTEN-loss and nuclear atypia of EIN in endometrial biopsies can predict the existence of a concurrent endometrial carcinoma. Gynecol Oncol, 119, 516-9.
  20. Salman MC, Usubutun A, Boynukalin K, Yuce K (2010). Comparison of WHO and endometrial intraepithelial neoplasia classifications in predicting the presence of coexistent malignancy in endometrial hyperplasia. J Gynecol Oncol, 21, 97-101.
  21. Shun CT, Wu MS, Lin MT, et al (2001). Immunohistochemical evaluation of cadherin and catenin expression in early gastric carcinomas: correlation with clinicopathologic characteristics and Helicobacter pylori infection. Oncology, 60, 339-45.
  22. Wong CM, Fan ST, Ng IO (2001). beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer, 92, 136-45.<136::AID-CNCR1301>3.0.CO;2-R
  23. Yang YF, Liao YY, Peng NF, et al (2012). Prediction of coexistent carcinomas risks by subjective EIN diagnosis and comparison with WHO classification in endometrial hyperplasias. Pathol Res Pract, 208, 708-12.
  24. Zhou JJ, Luo Q, Yan W (2008). Endometrial intraepithelial neoplasia: a clinicopathologic analysis of 53 cases. Chin J Diag Pathol, 15, 438-40. (in Chinese)

Cited by

  1. Risk Factors for Endometrial Hyperplasia Concomitant Endometrial Polyps in Pre- and Post-menopausal Women vol.15, pp.13, 2014,
  2. Estrogen receptor β: the guardian of the endometrium vol.21, pp.2, 2014,